Robert Joseph Cobuzzi Jr.
CIK 1799838 · View on SEC EDGAR ↗
First SEC filing: Feb. 14, 2025 · Latest: Feb. 14, 2025
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| March 18, 2022 | CRVO | P | 5,000 | $0.50 | $2,500 | 5,000 Direct | — | Acquired | -92.9% (price as of 2026-08-25) |
| Nov. 16, 2020 | CRVO | P | 14,000 | $0.66 | $9,240 | 14,000 Direct | — | Acquired | -94.6% (price as of 2026-08-25) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 4, 2025 | CRVO | Stock Option (Right to Buy) | Common Stock (27,000) | $2.30 | Feb. 4, 2035 | 27,000 | Acquired |
| Jan. 26, 2024 | CRVO | Stock Option (Right to Buy) | Common Stock (55,721) | $9.05 | Jan. 26, 2034 | 55,721 | Acquired |
| Sept. 15, 2023 | CRVO | Stock Option (Right to Buy) | Common Stock (16,000) | $5.33 | Sept. 15, 2033 | 16,000 | Acquired |
| Jan. 31, 2023 | CRVO | Restricted Stock Unit | Common Stock (327) | — | — | 327 | Disposed |
| Oct. 31, 2022 | CRVO | Restricted Stock Unit | Common Stock (327) | — | — | 327 | Disposed |
| Aug. 1, 2022 | CRVO | Restricted Stock Unit | Common Stock (327) | — | — | 327 | Disposed |
| May 2, 2022 | CRVO | Restricted Stock Unit | Common Stock (327) | — | — | 327 | Disposed |
| April 18, 2022 | CRVO | Series C Convertible Preferred Stock [F1] | Common Stock | — | — | 100 | Disposed |
| March 18, 2022 | CRVO | Series C Convertible Preferred Stock [F1] | Common Stock (5,000) | $0.50 | — | 5,000 | Acquired |
| Jan. 31, 2022 | CRVO | Restricted Stock Unit | Common Stock (16,350) | — | — | 16,350 | Disposed |
| Jan. 27, 2022 | CRVO | Stock Option (Right to Buy) | Common Stock (764,357) | $0.24 | Jan. 27, 2032 | 764,357 | Acquired |
| Nov. 1, 2021 | CRVO | Restricted Stock Unit | Common Stock (16,350) | — | — | 16,350 | Disposed |
| Nov. 1, 2021 | CRVO | Restricted Stock Units | Common Stock (16,350) | — | — | 16,350 | Disposed |
| March 1, 2021 | CRVO | Stock Option (Right to Buy) | Common Stock (53,713) | $1.11 | March 1, 2031 | 53,713 | Acquired |
| March 1, 2021 | CRVO | Stock Option (Right to Buy) | Common Stock (161,139) | $1.11 | March 1, 2031 | 161,139 | Acquired |
| Sept. 8, 2020 | CRVO | Stock Option (Right to Buy) | Common Stock (475,000) | $0.79 | Sept. 8, 2030 | 475,000 | Acquired |
| June 17, 2020 | CRVO | Stock Option (Right to Buy) | Common Stock (61,300) | $1.00 | June 17, 2030 | 61,300 | Acquired |
| Jan. 7, 2020 | CRVO | Stock Option (Right to Buy) | Common Stock (118,600) | $0.42 | June 30, 2021 | 118,600 | Acquired |
| Jan. 7, 2020 | CRVO | Restricted Stock Unit | Common Stock (98,100) | $0.51 | Dec. 31, 2022 | 98,100 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $238,551 | — | — | $42,606 | — | — | $636,376 | $917,533 |
| 2024 | $465,750 | — | — | $103,008 | $232,875 | — | $11,600 | $813,233 |
| 2023 | $375,000 | — | — | $316,524 | — | — | $11,600 | $703,124 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.